133 related articles for article (PubMed ID: 28060405)
21. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase.
Sutter G; Ohlmann M; Erfle V
FEBS Lett; 1995 Aug; 371(1):9-12. PubMed ID: 7664891
[TBL] [Abstract][Full Text] [Related]
22. Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.
Volz A; Sutter G
Adv Virus Res; 2017; 97():187-243. PubMed ID: 28057259
[TBL] [Abstract][Full Text] [Related]
23. Use of dual recombinant vaccinia virus vectors to assay viral glycoprotein-mediated fusion with transfection-resistant primary cell targets.
Yi Y; Singh A; Cutilli J; Collman RG
Methods Mol Biol; 2004; 269():333-46. PubMed ID: 15114024
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Recombinant MVA Selection Methods Based on F13L, D4R and K1L Genes.
Antoshkina IV; Glazkova DV; Urusov FA; Bogoslovskaya EV; Shipulin GA
Viruses; 2022 Mar; 14(3):. PubMed ID: 35336935
[TBL] [Abstract][Full Text] [Related]
25. Engineering recombinant poxviruses using a compact GFP-blasticidin resistance fusion gene for selection.
Wong YC; Lin LC; Melo-Silva CR; Smith SA; Tscharke DC
J Virol Methods; 2011 Jan; 171(1):295-8. PubMed ID: 21073901
[TBL] [Abstract][Full Text] [Related]
26. Induction of recombinant gene expression in stably transfected cell lines using attenuated vaccinia virus MVA expressing T7 RNA polymerase with a nuclear localisation signal.
Huemer HP; Strobl B; Shida H; Czerny CP
J Virol Methods; 2000 Mar; 85(1-2):1-10. PubMed ID: 10716333
[TBL] [Abstract][Full Text] [Related]
27. Enhanced genetic rescue of negative-strand RNA viruses: use of an MVA-T7 RNA polymerase vector and DNA replication inhibitors.
Kovacs GR; Parks CL; Vasilakis N; Udem SA
J Virol Methods; 2003 Jul; 111(1):29-36. PubMed ID: 12821194
[TBL] [Abstract][Full Text] [Related]
28. Activation of human dendritic cells by recombinant modified vaccinia virus Ankara vectors encoding survivin and IL-2 genes in vitro.
Tao R; Li L; Huang W; Zheng L
Hum Gene Ther; 2010 Jan; 21(1):98-108. PubMed ID: 19715401
[TBL] [Abstract][Full Text] [Related]
29. Construction and isolation of recombinant MVA.
Staib C; Drexler I; Sutter G
Methods Mol Biol; 2004; 269():77-100. PubMed ID: 15114009
[TBL] [Abstract][Full Text] [Related]
30. Vectors for recombinational cloning and gene expression in mammalian cells using modified vaccinia virus Ankara.
Pradeau-Aubreton K; Ruff M; Garnier JM; Schultz P; Drillien R
Anal Biochem; 2010 Sep; 404(1):103-5. PubMed ID: 20450873
[TBL] [Abstract][Full Text] [Related]
31. Gene expression using the vaccinia virus/ T7 RNA polymerase hybrid system.
Elroy-Stein O; Moss B
Curr Protoc Protein Sci; 2001 May; Chapter 5():Unit5.15. PubMed ID: 18429181
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara.
Ober BT; Brühl P; Schmidt M; Wieser V; Gritschenberger W; Coulibaly S; Savidis-Dacho H; Gerencer M; Falkner FG
J Virol; 2002 Aug; 76(15):7713-23. PubMed ID: 12097585
[TBL] [Abstract][Full Text] [Related]
33. Gene expression using the vaccinia virus/T7 RNA polymerase hybrid system.
Elroy-Stein O; Moss B
Curr Protoc Mol Biol; 2001 May; Chapter 16():Unit16.19. PubMed ID: 18265126
[TBL] [Abstract][Full Text] [Related]
34. High-throughput baculovirus expression in insect cells.
Hitchman RB; Possee RD; King LA
Methods Mol Biol; 2012; 824():609-27. PubMed ID: 22160923
[TBL] [Abstract][Full Text] [Related]
35. Low-level transforming activity of an activated Ras gene under the control of a vaccinia virus p40 promoter is abrogated by truncation of the Ras cDNA.
Cutler ML; Shupert WL; Schlom J; Kantor J
Vaccine; 1999 May; 17(18):2275-83. PubMed ID: 10403595
[TBL] [Abstract][Full Text] [Related]
36. Construction and isolation of recombinant vaccinia virus using genetic markers.
Lorenzo MM; Galindo I; Blasco R
Methods Mol Biol; 2004; 269():15-30. PubMed ID: 15114004
[TBL] [Abstract][Full Text] [Related]
37. Human tumor growth is inhibited by a vaccinia virus carrying the E2 gene of bovine papillomavirus.
Valdez Graham V; Sutter G; José MV; García-Carranca A; Erfle V; Moreno Mendoza N; Merchant H; Rosales R
Cancer; 2000 Apr; 88(7):1650-62. PubMed ID: 10738224
[TBL] [Abstract][Full Text] [Related]
38. A Deleted Deletion Site in a New Vector Strain and Exceptional Genomic Stability of Plaque-Purified Modified Vaccinia Ankara (MVA).
Jordan I; Horn D; Thiele K; Haag L; Fiddeke K; Sandig V
Virol Sin; 2020 Apr; 35(2):212-226. PubMed ID: 31833037
[TBL] [Abstract][Full Text] [Related]
39. Vaccinia virus as vector to express ion channel genes.
Karschin A; Thorne BA; Thomas G; Lester HA
Methods Enzymol; 1992; 207():408-23. PubMed ID: 1382194
[No Abstract] [Full Text] [Related]
40. Transient selection during vaccinia virus recombination with insertion vectors without selectable markers.
Kurilla MG
Biotechniques; 1997 May; 22(5):906-10. PubMed ID: 9149873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
